Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 52 articles:
HTML format



Single Articles


    March 2024
  1. STEADMAN JA, Glasgow AE, Neequaye NN, Habermann EB, et al
    Distinct presentation of melanoma in Black patients may inform strategies to improve outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27608.
    PubMed     Abstract available


  2. KADHUM M, Mayr L, Pope-Jones S, Cubitt J, et al
    Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27617.
    PubMed     Abstract available


    November 2023
  3. MALEKZADEH P, Brady MS
    Adjuvant therapy for stage IIB + IIC melanoma.
    J Surg Oncol. 2023 Nov 30. doi: 10.1002/jso.27534.
    PubMed    


  4. KAKISH H, Lal T, Thuener JE, Bordeaux JS, et al
    Is sentinel lymph node biopsy needed for lentigo maligna melanoma?
    J Surg Oncol. 2023 Nov 29. doi: 10.1002/jso.27543.
    PubMed     Abstract available


  5. GOYAL A, Fei-Zhang DJ, Pawlik TM, Bentrem DJ, et al
    Associations of social vulnerability with truncal and extremity melanomas in the United States.
    J Surg Oncol. 2023 Nov 27. doi: 10.1002/jso.27532.
    PubMed     Abstract available


  6. KAKISH H, Drigotas C, Ahmed FA, Elshami M, et al
    The effect of surgical timing in nonmetastatic melanoma.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27507.
    PubMed     Abstract available


  7. ASAI Y, Yanagawa N, Osakabe M, Yamada N, et al
    The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
    J Surg Oncol. 2023 Nov 2. doi: 10.1002/jso.27487.
    PubMed     Abstract available


    September 2023
  8. LIN X, Sun W, Ren M, Xu Y, et al
    Prediction of nonsentinel lymph node metastasis in acral melanoma with positive sentinel lymph nodes.
    J Surg Oncol. 2023 Sep 10. doi: 10.1002/jso.27438.
    PubMed     Abstract available


    July 2023
  9. FASTNER S, Hieken TJ, McWilliams RR, Hyngstrom J, et al
    Anorectal melanoma.
    J Surg Oncol. 2023 Jul 3. doi: 10.1002/jso.27381.
    PubMed     Abstract available


    April 2023
  10. ASARE EA, Fisher SB, Chiang YJ, Haydu LE, et al
    Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary management.
    J Surg Oncol. 2023 Apr 3. doi: 10.1002/jso.27267.
    PubMed     Abstract available


    March 2023
  11. HOLTKAMP LHJ, Lo SN, Thompson JF, Spillane AJ, et al
    Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection.
    J Surg Oncol. 2023 Mar 27. doi: 10.1002/jso.27245.
    PubMed     Abstract available


  12. SANTAMARIA-BARRIA JA, Matsuba C, Khader A, Scholar AJ, et al
    Age-related next-generation sequencing mutational analysis in 1196 melanomas.
    J Surg Oncol. 2023 Mar 20. doi: 10.1002/jso.27239.
    PubMed     Abstract available


  13. HOSEIN S, Drebin HM, Kurtansky NR, Olofsson Bagge R, et al
    Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    J Surg Oncol. 2023 Mar 11. doi: 10.1002/jso.27231.
    PubMed     Abstract available


    December 2022
  14. LEONARD LD, Beaty L, Thomas M, Quinn C, et al
    Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma.
    J Surg Oncol. 2022 Dec 1. doi: 10.1002/jso.27153.
    PubMed     Abstract available


    November 2022
  15. LI WY
    The role of electrochemotherapy in dermal metastases.
    J Surg Oncol. 2022;126:1148.
    PubMed    


    October 2022
  16. COIT DG, Ariyan CE
    Fifty years of progress in surgical oncology: Melanoma.
    J Surg Oncol. 2022;126:888-895.
    PubMed     Abstract available


    September 2022
  17. BAINVOLL L, Mandelbaum RS, Worswick SD, Matsuo K, et al
    Anatomical location of melanoma: A gender-specific analysis.
    J Surg Oncol. 2022 Sep 29. doi: 10.1002/jso.27111.
    PubMed    


  18. MCKINLEY SK, Brady MS
    Neoadjuvant therapy for melanoma: A critical appraisal.
    J Surg Oncol. 2022 Sep 19. doi: 10.1002/jso.27089.
    PubMed     Abstract available


  19. LYNCH KT, Hu Y, Farrow NE, Song Y, et al
    Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
    J Surg Oncol. 2022 Sep 17. doi: 10.1002/jso.27100.
    PubMed     Abstract available


    July 2022
  20. STRAKER RJ, Tortorello GN, Sharon CE, Keele LJ, et al
    Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanoma.
    J Surg Oncol. 2022 Jul 28. doi: 10.1002/jso.27021.
    PubMed     Abstract available


  21. MARSH KM, Lattimore CM, Cramer CL, Slingluff CL Jr, et al
    Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma.
    J Surg Oncol. 2022 Jul 23. doi: 10.1002/jso.27022.
    PubMed     Abstract available


  22. SALIM DN, Obinah MPB, Ternov NK, McCullagh MJD, et al
    Fine needle and core needle ultrasound guided biopsies for assessing suspected melanoma metastasis in lymph nodes and subcutaneous tissue.
    J Surg Oncol. 2022 Jul 6. doi: 10.1002/jso.26998.
    PubMed     Abstract available


    March 2022
  23. WHITMAN ED, Guenther JM
    RE: More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    J Surg Oncol. 2022 Mar 30. doi: 10.1002/jso.26775.
    PubMed    


  24. YAN MK, Adler NR, Pan Y, Chamberlain A, et al
    Yield of baseline imaging for distant metastases in high-risk primary melanoma.
    J Surg Oncol. 2022 Mar 9. doi: 10.1002/jso.26846.
    PubMed     Abstract available


  25. MATSUO K, Nishio S, Ogata D, Kato T, et al
    Treatment specialty-specific characteristics and outcomes in women with vulvo-vaginal melanoma: A JGOG-JSCS joint study.
    J Surg Oncol. 2022 Mar 3. doi: 10.1002/jso.26835.
    PubMed    


  26. CHAN BKY, Carrion-Alvarez L, Telfer R, Rehman AH, et al
    Surgical management of suspected gallbladder cancer: The role of intraoperative frozen section for diagnostic confirmation.
    J Surg Oncol. 2022;125:399-404.
    PubMed     Abstract available


  27. WITT RG, Cope B, Chiang YJ, Newhook T, et al
    Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy.
    J Surg Oncol. 2022;125:719-729.
    PubMed     Abstract available


  28. ECKHOFF A, Farrow NE, Silvestri C, Stroobant E, et al
    How much time is enough? Sentinel lymph node mapping time depends on the radiotracer agent.
    J Surg Oncol. 2022;125:712-718.
    PubMed     Abstract available


    January 2022
  29. SHARIB J, Slingluff CL Jr, Beasley GM
    Melanoma trials that defined surgical management: Overview of trials that established NCCN margin guidelines.
    J Surg Oncol. 2022;125:28-33.
    PubMed     Abstract available


  30. FARIES MB
    Melanoma trials that defined surgical management.
    J Surg Oncol. 2022;125:34-37.
    PubMed     Abstract available


  31. PATEL A, Skitzki J
    Melanoma trials that defined surgical management: Brief overview of current/upcoming adjuvant/neoadjuvant trials.
    J Surg Oncol. 2022;125:38-45.
    PubMed     Abstract available


    December 2021
  32. YAN M, Rose PS, Houdek MT, Moran SL, et al
    Outcomes of the keystone perforator island flap for oncologic reconstruction of the back.
    J Surg Oncol. 2021;124:1002-1007.
    PubMed     Abstract available


    November 2021
  33. JAEGER ZJ, Williams GA, Chen L, Mhlanga JC, et al
    (18) F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma.
    J Surg Oncol. 2021 Nov 6. doi: 10.1002/jso.26737.
    PubMed     Abstract available


  34. RENTROIA-PACHECO B, Tjien-Fooh FJ, Quattrocchi E, Kobic A, et al
    Clinicopathologic models predicting non-sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node?
    J Surg Oncol. 2021 Nov 4. doi: 10.1002/jso.26736.
    PubMed     Abstract available


    October 2021
  35. WEITEMEYER MB, Helvind NM, Brinck AM, Holmich LR, et al
    More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    J Surg Oncol. 2021 Oct 21. doi: 10.1002/jso.26723.
    PubMed     Abstract available


    September 2021
  36. DUNNE JA, Adigbli G
    The changing landscape in management of desmoplastic melanoma.
    J Surg Oncol. 2021 Sep 17. doi: 10.1002/jso.26677.
    PubMed    


  37. SUBRAMANIAN S, Han G, Olson N, Leong SP, et al
    Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.
    J Surg Oncol. 2021 Sep 17. doi: 10.1002/jso.26678.
    PubMed     Abstract available


  38. CORSINI EM, Mitchell KG, Zhou N, Bernatchez C, et al
    Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
    J Surg Oncol. 2021;124:699-703.
    PubMed     Abstract available


    August 2021
  39. DOWNS JS, Subramaniam S, Henderson MA, Paton E, et al
    A survey of surgical management of the sentinel node positive melanoma patient in the post-MSLT2 era.
    J Surg Oncol. 2021 Aug 18. doi: 10.1002/jso.26641.
    PubMed     Abstract available


    July 2021
  40. MULDER EEAP, Stahlie EHA, Verver D, Lemstra C, et al
    False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T-VEC).
    J Surg Oncol. 2021 Jul 8. doi: 10.1002/jso.26607.
    PubMed     Abstract available


    June 2021
  41. NARANG J, Hue JJ, Bingmer K, Hardacre JM, et al
    Sentinel lymph node biopsy guideline concordance in melanoma: Analysis of the National Cancer Database.
    J Surg Oncol. 2021 Jun 9. doi: 10.1002/jso.26565.
    PubMed     Abstract available


  42. DECKERS EA, Kruijff S, Bastiaannet E, van Ginkel RJ, et al
    Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
    J Surg Oncol. 2021 Jun 4. doi: 10.1002/jso.26555.
    PubMed     Abstract available


    March 2021
  43. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed     Abstract available


  44. THOMAS D, Bello DM
    Adjuvant immunotherapy for melanoma.
    J Surg Oncol. 2021;123:789-797.
    PubMed     Abstract available


    February 2021
  45. HUI JYC, Burke E, Broman KK, Marmor S, et al
    Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study.
    J Surg Oncol. 2021;123:646-653.
    PubMed     Abstract available


    December 2020
  46. HOUDEK MT, Honig RL, Mallett KE, Moran SL, et al
    Utility of toe fillet flaps for reconstruct of the forefoot in cases of plantar melanoma.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26348.
    PubMed    


  47. BREDBECK BC, Mubarak E, Zubieta DG, Tesorero R, et al
    Management of the positive sentinel lymph node in the post-MSLT-II era.
    J Surg Oncol. 2020;122:1778-1784.
    PubMed     Abstract available


    November 2020
  48. PINERO-MADRONA A, Nicolas-Ruiz F, Rull-Ortuno R, Vidal-Sicart S, et al
    Correlation between ferromagnetic and isotopic tracers for sentinel lymph node detection in cutaneous melanoma: IMINEM study.
    J Surg Oncol. 2020 Nov 25. doi: 10.1002/jso.26303.
    PubMed     Abstract available


  49. YAMASHITA TS, Pockaj BA, Bagaria SP, Flotte TJ, et al
    Clinical significance of SLN benign capsular nevi in patients with melanoma.
    J Surg Oncol. 2020;122:1043-1049.
    PubMed     Abstract available


    October 2020
  50. BLEICHER J, Swords DS, Mali ME, McGuire L, et al
    Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance.
    J Surg Oncol. 2020 Oct 24. doi: 10.1002/jso.26214.
    PubMed     Abstract available


  51. LEE AY, Brady MS
    Neoadjuvant immunotherapy for melanoma.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26229.
    PubMed     Abstract available


  52. FRANKE V, Madu MF, Bierman C, Klop WMC, et al
    Challenges in sentinel node pathology in the era of adjuvant treatment.
    J Surg Oncol. 2020;122:964-972.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.